PRESTIGENSUMER HEALTHCARE ($PBH) posted quarterly earnings results for Q2 2027 on Thursday, November 5th. The company reported earnings of $1.13 per share, beating estimates of $1.08 by $0.05. The company also reported revenue of $336,310,000, beating estimates of $332,421,158 by $3,888,842.
You can see Quiver Quantitative's $PBH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PRESTIGENSUMER HEALTHCARE Hedge Fund Activity
We have seen 151 institutional investors add shares of PRESTIGENSUMER HEALTHCARE stock to their portfolio, and 195 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FULLER & THALER ASSET MANAGEMENT, INC. added 2,331,821 shares (+inf%) to their portfolio in Q2 2026, for an estimated $110,225,178
- BRANDES INVESTMENT PARTNERS, LP added 1,196,941 shares (+140.1%) to their portfolio in Q2 2026, for an estimated $56,579,401
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. removed 1,070,515 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $50,603,244
- CAPITAL RESEARCH GLOBAL INVESTORS removed 894,679 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $42,291,476
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 654,174 shares (+inf%) to their portfolio in Q2 2026, for an estimated $30,922,804
- ARIEL INVESTMENTS, LLC added 594,385 shares (+13.9%) to their portfolio in Q2 2026, for an estimated $28,096,578
- NORGES BANK removed 524,077 shares (-87.5%) from their portfolio in Q2 2026, for an estimated $24,773,119
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
